Umang Vohra
-
Cipla secures CDSCO approval to introduce ZEMDRI injection in India
The novel antibiotic plazomicin is a new intravenous (IV) minoglycoside indicated for the treatment of complicated urinary tract infections Cipla…
Read More » -
Cipla, CSIR-CDRI to advance ophthalmic antifungal treatment development
The collaboration aims to leverage the combined expertise and resources of both organisations to develop a safe and efficacious drug…
Read More » -
Cipla announces JV with Kemwell Biopharma Manipal Education & Medical Group in US
The JV is for global development and commercialisation of innovative cell therapy products Cipla (EU), UK a wholly-owned subsidiary of…
Read More » -
Cipla to hold 22.99% stake in the digital tech company GoApptiv
This will be Cipla’s third investment in GoApptiv, which will be made in a combination of equity shares and compulsorily…
Read More » -
Cipla Medpro South Africa to acquire Actor Pharma
This is a strategic acquisition for Cipla South Africa to unlock future growth opportunities and leverage cost synergies in the…
Read More » -
Cipla approves re-appointment of Umang Vohra as MD and GCEO for 5 years
Vohra had joined Cipla in 2015 and has been the MD and Global CEO of the company since September 1,…
Read More » -
Cipla announces Q3FY21 results
Strong demand, sustained cost optimisation and operational excellence drives EBITDA margin of 24.8 per cent Cipla announced its unaudited consolidated…
Read More »